Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: Used. pp. 506 1st Edition.
Da: Majestic Books, Hounslow, Regno Unito
EUR 83,63
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used. pp. 506.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 82,29
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used. pp. 506.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 528.
Da: Revaluation Books, Exeter, Regno Unito
EUR 82,98
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 528 pages. 9.25x6.10x1.19 inches. In Stock.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 2012
ISBN 10: 3642457711 ISBN 13: 9783642457715
Da: moluna, Greven, Germania
EUR 47,23
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 90,66
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Lingua: Inglese
Editore: Springer-Verlag Berlin and Heidelberg GmbH & Co. K, 1998
ISBN 10: 3540640851 ISBN 13: 9783540640851
Da: NEPO UG, Rüsselsheim am Main, Germania
EUR 91,36
Quantità: 1 disponibili
Aggiungi al carrelloGebundene Ausgabe. Condizione: Sehr gut. 506 Seiten ex Library Book aus einer Unternehmensbibliothek Sprache: Englisch Gewicht in Gramm: 969.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 2012
ISBN 10: 3642457711 ISBN 13: 9783642457715
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 53,49
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This RRCR-conference-volume marks 'number six' in a 20-year evolution of international conferences on the adjuvant therapy of primary breast cancer. Starting in 1978, a handful of some 80 en thusiastic breast cancer surgeons and oncologists, met in a se cluded mountain resort near st. Gallen in Eastern Switzerland, to exchange their early data of some pioneer trials on adjuvant sys temic therapy of early breast cancer, and to correlate their future research efforts to overcome the frustrating prognostic stagna tion of this dominant neoplastic disease in Western females dur ing the past decades. Repeated every 3-4 years, these St. Gallen International Conferences on Adjuvant Therapy of Primary Breast Cancer have continuously grown in numbers of partici pants and in normative, therapeutic influence by being published in major oncology journals [1-3], the last (6th) conference hav ing taken place from February 25-28, 1998 with more than 1800 attendees from over 50 countries worldwide. What is the fascination of adjuvant therapy in primary (early) breast cancer, and what has changed,during the last 3 years since March 1995, to justify another international gathering of this size, and of the world's leading experts in the field There is no question, that providing even more effective care and designing appropriate recommendations for the multitudes of patients with so-called early breast cancer or at high risk of developing the disease, remain highly important public health goals.
Da: preigu, Osnabrück, Germania
EUR 50,35
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Adjuvant Therapy of Primary Breast Cancer VI | Hans-Jörg Senn (u. a.) | Taschenbuch | xvi | Englisch | 2012 | Springer | EAN 9783642457715 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Condizione: As New. Unread book in perfect condition.
Condizione: New.
Condizione: New.
Condizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 125,39
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 113,92
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 2011
ISBN 10: 3642792804 ISBN 13: 9783642792809
Da: moluna, Greven, Germania
EUR 92,27
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 132,00
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 144,15
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Revaluation Books, Exeter, Regno Unito
EUR 154,13
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. reprint edition. 316 pages. 9.25x6.10x0.80 inches. In Stock.
Condizione: New. pp. 316.
Da: Revaluation Books, Exeter, Regno Unito
EUR 154,83
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. reprint edition. 356 pages. 9.25x6.10x0.79 inches. In Stock.
Condizione: New. pp. 360.
Da: preigu, Osnabrück, Germania
EUR 95,15
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Bisphosphonates in Clinical Oncology | The Development of Pamidronate | Beat Thürlimann | Taschenbuch | xiv | Englisch | 2011 | Springer | EAN 9783642641480 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 2011
ISBN 10: 3642641482 ISBN 13: 9783642641480
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 106,99
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The book gives an overview of the clinical developments in the use of bisphosphonates in clinical oncology. The first part pre sents the composition, physiology, and pathophysiology of bone. Next is a section giving insight into mechanisms of bone resorp tion, bone formation, and bone remodeling, a field in which I was most influenced by O. L. M. Bijvoet and H. Fleisch. The sec ond part summarizes the pharmacological treatments for disor ders of bone remodeling. The clinical aspects of tumor-induced hypercalcemia and its management are described in detail, in cluding our first prospective randomized crossover study testing pamidronate versus mithramycin. The bisphosphonates were in troduced in clinical oncology by endocrinologists. The same was true for our institution in 1986, when P. Burckhardt proposed testing pamidronate in the above-mentioned trial in his institu tion (CHUV) and in our department. The impressive results ob tained in the hypercalcemia trial stimulated our interest, and we actively investigated the use of pamidronate to counteract osteo lytic bone destruction in cancer patients. These investigations are presented and discussed in the third part. They represent the interdisciplinary work involving many co-workers of the Depart ment of Internal Medicine C and other institutes of the Interdis ciplinary Oncology Center St. Gallen (IOSG), which I was privi leged to chair for 10 years. Initially, a pharmacokinetic study was performed in order to optimize and facilitate the administration of the drug to patients with malignant osteolytic bone disease.